| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Teva Pharmaceutical Industries Limited (NYSE: TEVA)
TEVA Technical Analysis
5
| As on 31st Dec 2024 TEVA STOCK Price closed @ 22.04 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 11.67 & Strong Buy for SHORT-TERM with Stoploss of 9.58 we also expect STOCK to react on Following IMPORTANT LEVELS. |
TEVASTOCK Price
| Open | 22.32 | Change | Price | % |
| High | 22.57 | 1 Day | -0.28 | -1.25 |
| Low | 21.86 | 1 Week | 0.73 | 3.43 |
| Close | 22.04 | 1 Month | 5.56 | 33.74 |
| Volume | 6279063 | 1 Year | 13.48 | 157.48 |
| 52 Week High 22.77 | 52 Week Low 8.12 | ||||
NYSE USA Most Active Stocks
| FSR | 0.02 | 0.00% |
| DDR | 15.44 | -4.46% |
| TWTR | 53.70 | 0.66% |
| SWN | 7.11 | -0.56% |
| BACA-U | 302.00 | 0.67% |
| PLTR | 75.63 | -2.71% |
| RPAI | 13.15 | -3.17% |
| LTHM | 16.51 | -8.53% |
| F | 9.90 | 0.20% |
| NXU | 1.48 | -1.33% |
NYSE USA Top Gainers Stocks
NYSE USA Top Losers Stocks
| TEVA Daily Charts |
TEVA Intraday Charts |
Whats New @ Bazaartrend |
TEVA Free Analysis |
|
|
TEVA Important Levels Intraday
| RESISTANCE | 23.41 |
| RESISTANCE | 22.97 |
| RESISTANCE | 22.70 |
| RESISTANCE | 22.43 |
| SUPPORT | 21.65 |
| SUPPORT | 21.38 |
| SUPPORT | 21.11 |
| SUPPORT | 20.67 |
TEVA Forecast January 2025
| 4th UP Forecast | 25.47 |
| 3rd UP Forecast | 24.37 |
| 2nd UP Forecast | 23.69 |
| 1st UP Forecast | 23.01 |
| 1st DOWN Forecast | 21.07 |
| 2nd DOWN Forecast | 20.39 |
| 3rd DOWN Forecast | 19.71 |
| 4th DOWN Forecast | 18.61 |
TEVA Weekly Forecast
| 4th UP Forecast | 23.08 |
| 3rd UP Forecast | 22.75 |
| 2nd UP Forecast | 22.54 |
| 1st UP Forecast | 22.33 |
| 1st DOWN Forecast | 21.75 |
| 2nd DOWN Forecast | 21.54 |
| 3rd DOWN Forecast | 21.33 |
| 4th DOWN Forecast | 21.00 |
TEVA Forecast2025
| 4th UP Forecast | 50.46 |
| 3rd UP Forecast | 41.35 |
| 2nd UP Forecast | 35.71 |
| 1st UP Forecast | 30.08 |
| 1st DOWN Forecast | 14 |
| 2nd DOWN Forecast | 8.37 |
| 3rd DOWN Forecast | 2.73 |
| 4th DOWN Forecast | -6.38 |
Teva Pharmaceutical Industries Limited ( NYSE USA Symbol : TEVA )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
TEVA Business Profile
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, ointments, and creams. It also develops, manufactures, and sells active pharmaceutical ingredients. In addition, it focuses on the central nervous system, pain, respiratory, and oncology areas. Its products in the central nervous system and pain area include Copaxone for the treatment of relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine; and AUSTEDO for the treatment of tardive dyskinesia and chorea associated with Huntington disease. The company's products in the respiratory market comprise ProAir, QVAR, ProAir Digihaler, AirDuo Digihaler, and ArmonAir Digihaler, BRALTUS, CINQAIR/CINQAERO, DuoResp Spiromax, and AirDuo RespiClick/ArmonAir RespiClick for the treatment of asthma and chronic obstructive pulmonary disease. Its products in the oncology market include Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim. The company was founded in 1901 and is based in Tel Aviv-Yafo, Israel. Address: 124 Dvora Hanevi?a Street, Tel Aviv, Israel, 6944020
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service